February 13, 2025- QuidelOrtho Corporation announced financial results for the fourth quarter and full-year ended December 29, 2024. The Company reported fourth quarter 2024 total revenue of $708 million, compared to $743 million in the prior year period. The year-over-year decrease was due to lower COVID-19 and influenza revenue. Foreign currency translation did not significantly impact the Company’s fourth quarter 2024 revenue.
GAAP diluted loss per share for the fourth quarter of 2024 was $2.28, compared to diluted earnings per share (“EPS”) of $0.10 in the prior year period. GAAP net loss for the fourth quarter of 2024 was $153 million, compared to net income of $7 million in the prior year period. GAAP operating loss for the fourth quarter of 2024 was $100 million, compared to an operating income of $40 million in the prior year period, and GAAP operating margin was (14)% in the fourth quarter of 2024, compared to 5% in the prior year period. Fourth quarter 2024 results included $37 million in integration-related charges.